ZBC-260

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameZBC-260
Drug Alias NameZBC-260
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsPituitary Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHuashan Hospital Affiliated To Fudan University
China Registration ClassN/A

Develop Information

Active CompaniesHuashan Hospital Affiliated To Fudan University
Inactive CompaniesN/A
Active IndicationsPituitary Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A